Quadri Meningo Vaccine
Quadri Meningo Vaccine is a prescription immunization used to prevent invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, Y, and W-135. It is recommended for children (from 2 months), adolescents, and adults based on official immunization guidelines. Administered by a healthcare professional, it helps develop immunity against potentially life-threatening bacterial meningitis.
Contact us for sales assistance from our Biomedical Engineer.
Features:
-
Protects against four major meningococcal serogroups: A, C, Y & W-135
-
Suitable for infants (from 2 months), children, adolescents, and adults
-
Helps prevent meningitis and bloodstream infections (septicemia)
-
Well-tolerated with a generally mild side effect profile
-
Can be co-administered with other routine vaccines under guidance
-
Backed by clinical studies and WHO/CDC immunization guidelines
| Technical Specification |
|
|---|
- 1.0 ml in 1 vial
-
Provides broad-spectrum protection against four deadly strains of Neisseria meningitidis
-
Helps prevent outbreaks in high-risk populations such as college students, travelers, or military personnel
-
Reduces hospitalizations and complications from bacterial meningitis
-
Essential for travel to meningitis belt regions or Hajj pilgrimage
-
Can be part of routine immunization or catch-up vaccination schedules
-
Improves public health by lowering the carriage rate of meningococcal bacteria
